How do you prepare an insulin drip?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Prepare an Insulin Drip

Prepare a continuous insulin infusion at a standardized concentration of 1 unit/mL using regular human insulin in 0.9% normal saline, and prime the tubing with a 20-mL waste volume before connecting to the patient. 1

Standard Preparation Protocol

Concentration and Solution

  • Use regular human insulin at a concentration of 1 unit/mL for all continuous infusions in critically ill patients 1
  • Mix the insulin in 0.9% normal saline solution as the standard diluent 1, 2
  • For example: Add 100 units of regular insulin to 100 mL of normal saline to achieve 1 unit/mL concentration 1

Tubing Preparation (Critical Step)

  • Prime new IV tubing with at least 20 mL of the insulin solution as waste before initiating therapy 1
  • This priming step is essential because insulin adsorbs to polyvinylchloride (PVC) surfaces of IV tubing 3
  • After the initial 50 mL wash-out, at least 75% of expected insulin is delivered in the first 50 mL, and 100% thereafter 3
  • An insulin concentration of at least 25 units per 500 mL (0.05 units/mL) with 50 mL tubing flush eliminates the need for albumin additives 3

Special Considerations for Concentrated Preparations

Higher Concentration Options

  • For patients requiring high-dose insulin (such as calcium channel blocker or beta blocker overdose), concentrated insulin at 16 units/mL in 0.9% saline is stable for 14 days both refrigerated and at room temperature 2
  • This higher concentration prevents fluid volume overload in patients requiring large insulin doses 2
  • Concentrated preparations ranging from 2-fold to 5-fold (U-200 to U-500) are available but primarily for subcutaneous use 4, 5

Visual Inspection Before Use

Quality Check

  • Inspect the insulin vial before each use for clumping, frosting, precipitation, or changes in clarity or color 1, 6
  • Regular insulin and rapid-acting insulins should appear clear 1
  • Any visual changes may indicate loss of potency and the vial should be replaced 1

Storage Guidelines

Before Preparation

  • Unopened insulin vials should be refrigerated at 36-46°F (2-8°C) 6
  • Avoid extreme temperatures (<36°F or >86°F) and excess agitation to prevent loss of potency 1, 6
  • Insulin in use may be kept at room temperature 1

Common Pitfalls to Avoid

  • Failing to prime the tubing adequately: This results in significant insulin loss to PVC surfaces and unpredictable dosing in the initial hours 3
  • Using the wrong insulin type: Only regular human insulin should be used for IV infusions; do not use rapid-acting analogs, NPH, or long-acting insulins intravenously 1
  • Mixing with incompatible solutions: No other medication should be mixed with insulin unless specifically approved 1
  • Not inspecting for visual changes: Using insulin that has changed appearance can result in inadequate glycemic control 1, 6

When to Use IV Insulin Infusion

  • Preferred for hemodynamically unstable patients with hyperglycemia 1
  • Essential for patients with type 1 diabetes in critical care settings 1
  • Required when rapid titration and immediate flexibility are needed for tight glycemic control 1
  • Should not be initiated in patients with hypothermia, significant edema, or frequent interruptions of dextrose intake 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Concentrated insulins in current clinical practice.

Diabetes research and clinical practice, 2019

Guideline

Insulin Lispro Administration and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.